Zayas, Jacqueline
Ruddy, Kathryn J.
Olson, Janet E.
Couch, Fergus J.
Bauer, Brent A.
Mallory, Molly J.
Yang, Ping
Zahrieh, David
Athreya, Arjun P.
Loprinzi, Charles L.
Cathcart-Rake, Elizabeth J.
Funding for this research was provided by:
Tracy Starr Breast Cancer Research Fund Award
National Institutes of Health (T32 GM065841)
Article History
Received: 24 May 2019
Accepted: 27 March 2020
First Online: 6 April 2020
Compliance with ethical standards
:
: CLL has a consulting/advisory role with Pled Pharma, Disarm Therapeutics, Metys, and Asahi Kasei. KRJ inherited and then sold Merck and Pfizer stock in February 2018.
: This study was approved by Mayo Clinic Institutional Review Board (IRB) (IRB nos 181504 and 18006395) in accordance with ethical standards.
: Informed consent was obtained from all individual participants included in the study.